Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | INI-4001 |
| Trade Name | |
| Synonyms | INI 4001|INI4001 |
| Drug Descriptions |
INI-4001 is a TLR7/8 agonist, which potentially enhances immune response (PMID: 38258117). |
| DrugClasses | TLR7 Agonist 13 TLR8 Agonist 10 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Atezolizumab + INI-4001 | Atezolizumab INI-4001 | 0 | 1 |
| Avelumab + INI-4001 | Avelumab INI-4001 | 0 | 1 |
| Cemiplimab + INI-4001 | Cemiplimab INI-4001 | 0 | 1 |
| Durvalumab + INI-4001 | Durvalumab INI-4001 | 0 | 1 |
| INI-4001 | INI-4001 | 0 | 1 |
| INI-4001 + Nivolumab | INI-4001 Nivolumab | 0 | 1 |
| INI-4001 + Pembrolizumab | INI-4001 Pembrolizumab | 0 | 1 |